GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » Cash Flow from Financing

Noevir Holdings Co (TSE:4928) Cash Flow from Financing : 円-7,667 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Noevir Holdings Co paid 円0 Mil more to buy back shares than it received from issuing new shares. It received 円0 Mil from issuing more debt. It paid 円0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent 円76 Mil paying cash dividends to shareholders. It spent 円21 Mil on other financial activities. In all, Noevir Holdings Co spent 円97 Mil on financial activities for the three months ended in Mar. 2024.


Noevir Holdings Co Cash Flow from Financing Historical Data

The historical data trend for Noevir Holdings Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co Cash Flow from Financing Chart

Noevir Holdings Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,287.00 -6,962.00 -7,181.00 -7,380.00 -7,493.00

Noevir Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.00 -25.00 -82.00 -7,463.00 -97.00

Noevir Holdings Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Noevir Holdings Co's Cash from Financing for the fiscal year that ended in Sep. 2023 is calculated as:

Noevir Holdings Co's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-7,667 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noevir Holdings Co  (TSE:4928) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Noevir Holdings Co's issuance of stock for the three months ended in Mar. 2024 was 円0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Noevir Holdings Co's repurchase of stock for the three months ended in Mar. 2024 was 円0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Noevir Holdings Co's net issuance of debt for the three months ended in Mar. 2024 was 円0 Mil. Noevir Holdings Co received 円0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Noevir Holdings Co's net issuance of preferred for the three months ended in Mar. 2024 was 円0 Mil. Noevir Holdings Co paid 円0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Noevir Holdings Co's cash flow for dividends for the three months ended in Mar. 2024 was 円-76 Mil. Noevir Holdings Co spent 円76 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Noevir Holdings Co's other financing for the three months ended in Mar. 2024 was 円-21 Mil. Noevir Holdings Co spent 円21 Mil on other financial activities.


Noevir Holdings Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Noevir Holdings Co (TSE:4928) Business Description

Traded in Other Exchanges
N/A
Address
6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines